Cell and Gene Regulatory

  1. Navigating The Waters Of Compliance In Clinical Research 5/5/2026

    Strengthen your research processes by adopting secure systems, staying current with regulatory standards, and ensuring your team is consistently trained to manage data responsibly and efficiently.

  2. Here's How FDA's Accelerated Approval Pathway Has Evolved Since '24 5/5/2026

    FDA's accelerated approval guidance kicked off a rebalancing of new drug approval pathways. Since its 2024 release, the agency has been building on it in a few key areas.

  3. Control Software For Industrial Applications 5/1/2026

    Learn how integrated process control, scalable workflows, and secure automation help teams plan, run, and analyze bioprocesses efficiently across research, development, and manufacturing.

  4. The Stepwise Path Lilly Mapped From Paper To Digital Logbooks 4/30/2026

    Eli Lilly and Company started at the front lines, on the shop floor gathering operator input, when switching from paper to digital logbooks.

  5. How To Establish Strategic Readiness For First-In-Human Trials 4/29/2026

    Most teams realize too late that sequential planning creates delays. FIH readiness depends on aligning IND and clinical strategy early; otherwise, programs risk setbacks that stall execution and timelines.

  6. Data-Driven Predictive Maintenance And Production Transparency 4/29/2026

    Discover how integrated, data-driven solutions can help you reduce downtime, improve visibility, and streamline compliance across your manufacturing operations.

  7. Strengthening Drug Product CMC through Drug Product Science | AAPS 4/27/2026

    At AAPS, drug product experts discuss how formulation, stability, and analytical services enable robust CMC strategies, reduce development risk, and support confident regulatory decision‑making.

  8. Lipids CDMO Services: Custom Excipients Tailored To Your Needs 4/27/2026

    Advance your lipid‑based programs with a CDMO partner equipped to deliver customized excipients, proven scale‑up expertise, and reliable support from early development through commercialization.

  9. Start Smart With IRB-Approved, Data Rich Samples 4/27/2026

    Learn about end-to-end biospecimen solutions that combine vast inventories with custom collections and specialized lab services to ensure sample integrity and trial success.

  10. Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere 4/27/2026

    Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.